Open Access

COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer

  • Authors:
    • Xiaoxia Jiang
    • Mengjie Wu
    • Xin Xu
    • Liwei Zhang
    • Yingying Huang
    • Zhenzhen Xu
    • Kuifeng He
    • Haiyong Wang
    • Haohao Wang
    • Lisong Teng
  • View Affiliations

  • Published online on: August 1, 2019     https://doi.org/10.3892/mmr.2019.10548
  • Pages: 3103-3112
  • Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Dysregulation of collagen type XII α1 chain (COL12A1) has been found in several cancer types and could be involved in tumor progression. However, its clinical significance in gastric cancer (GC) remains under exploration. Online databases (Gene Expression Omnibus and UALCAN), reverse transcription‑quantitative PCR and immunohistochemistry were utilized in the present study to evaluate the expression of COL12A1 in GC tissues and cell lines. It was found that COL12A1 expression was notably upregulated in GC. Clinicopathological analysis showed that elevated COL12A1 expression was positively correlated with tumor invasiveness, metastasis and advanced clinical stage. The prognostic analysis suggested that high COL12A1 expression contributed to poor overall survival. Multivariate Cox analysis indicated that COL12A1 overexpression was a powerful independent prognostic indicator in patients with GC (hazard ratio, 1.896; 95% CI, 1.267‑2.837; P=0.002). The results highlighted the importance of COL12A1 in GC and suggested its potential role as a candidate for clinical outcome prediction and targeted therapy in patients with GC.
View Figures
View References

Related Articles

Journal Cover

October-2019
Volume 20 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiang X, Wu M, Xu X, Zhang L, Huang Y, Xu Z, He K, Wang H, Wang H, Teng L, Teng L, et al: COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer. Mol Med Rep 20: 3103-3112, 2019.
APA
Jiang, X., Wu, M., Xu, X., Zhang, L., Huang, Y., Xu, Z. ... Teng, L. (2019). COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer. Molecular Medicine Reports, 20, 3103-3112. https://doi.org/10.3892/mmr.2019.10548
MLA
Jiang, X., Wu, M., Xu, X., Zhang, L., Huang, Y., Xu, Z., He, K., Wang, H., Wang, H., Teng, L."COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer". Molecular Medicine Reports 20.4 (2019): 3103-3112.
Chicago
Jiang, X., Wu, M., Xu, X., Zhang, L., Huang, Y., Xu, Z., He, K., Wang, H., Wang, H., Teng, L."COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer". Molecular Medicine Reports 20, no. 4 (2019): 3103-3112. https://doi.org/10.3892/mmr.2019.10548